NCT06371235View on ClinicalTrials.gov

Study of the Transmission of Anti-interferon Type 1 Alpha Autoantibodies From Mother to Child Via the Placental Barrier

NANot yet recruitingINTERVENTIONAL

Enrollment

250

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

September 30, 2024

Study Completion Date

March 31, 2027

Conditions

Woman Suffering From a Pathology Frequently Associated With the Presence of These Anti-autoantibodies Type-I Interferons

Interventions

OTHER

Pregiferon

This Study aims to study the transmission of anti-interferon alpha autoantibodies from mother to child viaplacental barrier

All Listed Sponsors

lead

CerbaXpert

OTHER

NCT06371235 - Study of the Transmission of Anti-interferon Type 1 Alpha Autoantibodies From Mother to Child Via the Placental Barrier | Biotech Hunter | Biotech Hunter